FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dongsheng Tu

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Huan Jin; Naiqing Zhao; Dongsheng Tu
Weighted rank tests for noninferiority hypotheses based on paired survival times.
Paul E Goss; James N Ingle; Robert B Livingston; Silvana Martino; Hyman Muss; Edith A Perez; Kathleen I Pritchard; Nicholas J Robert; Lois E Shepherd; David A Cameron; Y Chavarri-Guerra; Nancy E Davidson; T Whelan; Dongsheng Tu
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole.
Ian Gilron; Dongsheng Tu; Ronald R Holden
Sensory and affective pain descriptors respond differentially to pharmacological interventions in neuropathic conditions.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dongsheng Tu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Huan Jin; Naiqing Zhao; Dongsheng Tu
Weighted rank tests for noninferiority hypotheses based on paired survival times.
Journal of biopharmaceutical statistics 2013;23(2):432-46.
2013: Paul E Goss; James N Ingle; Robert B Livingston; Silvana Martino; Hyman Muss; Edith A Perez; Kathleen I Pritchard; Nicholas J Robert; Lois E Shepherd; David A Cameron; Y Chavarri-Guerra; Nancy E Davidson; T Whelan; Dongsheng Tu
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(2):355-61.
2013: Ian Gilron; Dongsheng Tu; Ronald R Holden
Sensory and affective pain descriptors respond differentially to pharmacological interventions in neuropathic conditions.
The Clinical journal of pain 2013;29(2):124-31.
2012: Kishor M Wasan; Paul E Goss; P Haydn Pritchard; Lois Shepherd; Dongsheng Tu; James N Ingle
Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study.
Breast cancer research and treatment 2012;136(3):769-76.
2012: Huan Jin; Lois E Shepherd; Dongsheng Tu; Naiqing Zhao; Paul E Goss
Longer-term outcomes of letrozole versus placebo after 5 years of tamoxifen in the NCIC CTG MA.17 trial: analyses adjusting for treatment crossover.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(7):718-21.
2011: Frances P O'Malley; Lois E Shepherd; Dongsheng Tu; Irene L Andrulis; Vivien H C Bramwell; S Chia; D Huntsman; Mark N Levine; Kathleen I Pritchard
Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial.
Breast cancer research and treatment 2011;128(2):401-9.
2011: Paul E Goss; James N Ingle; Karen C Johnson; Lisa W Martin; Elizabeth Maunsell; Anne McTiernan; Pascal Pujol; Harriet Richardson; John Robbins; Gloria E Sarto; Dongsheng Tu; Jean Wactawski-Wende; Eric Winquist; José E Alés-Martínez; Angela M Cheung; Rowan T Chlebowski; Carol J Fabian; Patricia Farmer; Judy E Garber; Karen A Gelmon
Exemestane for breast-cancer prevention in postmenopausal women.
The New England journal of medicine 2011;364(25):2381-91.
2011: Neil Fleshner; Martin Gleave; Karen Hersey; Ken Jansz; Linda Kapusta; Louis Lacombe; D Robert Siemens; Simon Tanguay; Kiril Trpkov; Dongsheng Tu; Joseph Chin; Bryan Donnelly; Anne Farley; Wendy R Parulekar
Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(17):2386-90.
2011: H J Mackay; D Provencheur; M Heywood; Dongsheng Tu; Elizabeth A Eisenhauer; Amit Oza; R Meyer
Phase ii/iii study of intraperitoneal chemotherapy after neoadjuvant chemotherapy for ovarian cancer: ncic ctg ov.21.
Current oncology (Toronto, Ont.) 2011;18(2):84-90.
2011: Christopher M Booth; Pavlo Ohorodnyk; Liting Zhu; Dongsheng Tu; Ralph M Meyer
Randomised controlled trials in oncology closed early for benefit: trends in methodology, results, and interpretation.
European journal of cancer (Oxford, England : 1990) 2011;47(6):854-63.
2011: Xiaoqun Sun; Paul Peng; Dongsheng Tu
Phase II cancer clinical trials with a one-sample log-rank test and its corrections based on the Edgeworth expansion.
Contemporary clinical trials 2011;32(1):108-13.
2010: Helen J Mackay; Steven Gallinger; Ming S Tsao; C Meg McLachlin; Dongsheng Tu; Katharina Keiser; Elizabeth A Eisenhauer; Amit Oza
Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG).
European journal of cancer (Oxford, England : 1990) 2010;46(8):1365-73.
2009: Ian Gilron; Joan M Bailey; Dongsheng Tu; Ronald R Holden; Alan C Jackson; Robyn L Houlden
Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial.
Lancet 2009;374(9697):1252-61.
2009: Frances P O'Malley; S Chia; Dongsheng Tu; Lois E Shepherd; Mark N Levine; Vivien H C Bramwell; Irene L Andrulis; Kathleen I Pritchard
Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy.
Journal of the National Cancer Institute 2009;101(9):644-50.
2008: John R Goffin; Dongsheng Tu
Phase II stopping rules that employ response rates and early progression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(22):3715-20.
2008: Michael D Brundage; Andrea Bezjak; Dongsheng Tu; Michael Palmer; Joseph Pater
NCIC Clinical Trials Group experience of employing patient-reported outcomes in clinical trials: an illustrative study in a palliative setting.
Expert review of pharmacoeconomics & outcomes research 2008;8(3):243-53.
2008: James N Ingle; Dongsheng Tu; Joseph L Pater; Hyman Muss; Silvana Martino; Nicholas J Robert; Martine J Piccart; M Castiglione; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; David A Cameron; Michael J Palmer; Paul E Goss
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(5):877-82.
2008: Paul E Goss; James N Ingle; Joseph L Pater; Silvana Martino; Nicholas J Robert; Hyman Muss; Martine J Piccart; Monica Castiglione; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; David A Cameron; Michael J Palmer; Dongsheng Tu
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1948-55.
2008: Joseph L Pater; Dongsheng Tu; Lois Shepherd; James N Ingle; Paul E Goss
Decision making in adjuvant trials in breast cancer: the NCIC CTG MA.17 trial as an example.
Breast cancer research and treatment 2008;108(2):265-9.
2008: Michael Crump; Stefan Gluck; Dongsheng Tu; Doug Stewart; Mark Levine; Peter Kirkbride; Janet Dancey; Susan O'Reilly; Tsiporah Shore; Stephen Couban; Caroline Girouard; Susan Marlin; Lois Shepherd; Kathleen I Pritchard
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(1):37-43.
2008: M S Carey; Monica Bacon; Dongsheng Tu; L Butler; Andrea Bezjak; G C Stuart
The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
Gynecologic oncology 2008;108(1):100-5.
2007: Michael D Brundage; David Osoba; Andrea Bezjak; Dongsheng Tu; Michael Palmer; Joseph L Pater
Lessons learned in the assessment of health-related quality of life: selected examples from the National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(32):5078-81.
2007: Brian Findlay; Katia S Tonkin; M Crump; B Norris; M Trudeau; Martin E Blackstein; M Burnell; JR Skillings; D Bowman; D Walde; M Levine; K I Pritchard; Michael J Palmer; Dongsheng Tu; L Shepherd
A dose escalation trial of adjuvant cyclophosphamide and epirubicin in combination with 5-fluorouracil using G-CSF support for premenopausal women with breast cancer involving four or more positive nodes.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(10):1646-51.
2007: Dongsheng Tu
Under-smoothed kernel confidence intervals for the hazard ratio based on censored data.
Biometrical journal. Biometrische Zeitschrift 2007;49(3):474-83.
2007: Paul E Goss; James N Ingle; Silvana Martino; Nicholas J Robert; Hyman Muss; Martine J Piccart; Monica Castiglione; Dongsheng Tu; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; David A Cameron; Michael J Palmer; Joseph L Pater
Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2006-11.
2007: Deborah J Dudgeon; Eduardo Bruera; Bruno Gagnon; Sharon M Watanabe; Sharon J Allan; David G Warr; Susan M MacDonald; Colleen Savage; Dongsheng Tu; Joseph L Pater
A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients.
Journal of pain and symptom management 2007;33(4):365-71.
2006: Jianhua Liu; Dongsheng Tu; Janet Dancey; Leonard Reyno; Kathleen I Pritchard; Joseph L Pater; Lesley K Seymour
Quality of life analyses in a clinical trial of DPPE (tesmilifene) plus doxorubicin versus doxorubicin in patients with advanced or metastatic breast cancer: NCIC CTG Trial MA.19.
Breast cancer research and treatment 2006;100(3):263-71.
2006: Beverly Moy; Dongsheng Tu; Joseph L Pater; James N Ingle; Lois E Shepherd; Timothy J Whelan; Paul E Goss
Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1637-43.
2006: James N Ingle; Dongsheng Tu; Joseph L Pater; Silvana Martino; Nicholas J Robert; Hyman Muss; Martine J Piccart; Monica Castiglione; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; David A Cameron; Michael J Palmer; Paul E Goss
Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial.
Breast cancer research and treatment 2006;99(3):295-300.
2006: Edith A Perez; Robert G Josse; Kathleen I Pritchard; James N Ingle; Silvana Martino; Brian Findlay; Tamara N Shenkier; Richard G Tozer; Michael J Palmer; Lois E Shepherd; Shifang Liu; Dongsheng Tu; Paul E Goss
Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3629-35.
2006: H Hirte; I B Vergote; J R Jeffrey; R N Grimshaw; S Coppieters; B Schwartz; Dongsheng Tu; Anna Sadura; M Brundage; Lesley Seymour
A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: a National Cancer Institute of Canada Clinical Trials Group Study.
Gynecologic oncology 2006;102(2):300-8.
2006: Kathleen I Pritchard; Lois E Shepherd; Frances P O'Malley; Irene L Andrulis; Dongsheng Tu; Vivien H C Bramwell; Mark N Levine
HER2 and responsiveness of breast cancer to adjuvant chemotherapy.
The New England journal of medicine 2006;354(20):2103-11.
2005: Michael D Brundage; Deb Feldman-Stewart; A Leis; Andrea Bezjak; L Degner; K Velji; L Zetes-Zanatta; Dongsheng Tu; Paul Ritvo; Joseph L Pater
Communicating quality of life information to cancer patients: a study of six presentation formats.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6949-56.
2005: Timothy J Whelan; Paul E Goss; James N Ingle; Joseph L Pater; Dongsheng Tu; Kathleen Pritchard; Shifang Liu; Lois E Shepherd; Michael Palmer; Nicholas J Robert; Silvana Martino; Hyman Muss
Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6931-40.
2005: Paul E Goss; James N Ingle; Silvana Martino; Nicholas J Robert; Hyman Muss; Martine J Piccart; Monica Castiglione; Dongsheng Tu; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; David A Cameron; Michael J Palmer; Joseph L Pater
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.
Journal of the National Cancer Institute 2005;97(17):1262-71.
2005: John Goffin; Stefan David Baral; Dongsheng Tu; Dora Nomikos; Lesley Seymour
Objective responses in patients with malignant melanoma or renal cell cancer in early clinical studies do not predict regulatory approval.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5928-34.
2005: Mark N Levine; Kathleen I Pritchard; Vivien H C Bramwell; Lois E Shepherd; Dongsheng Tu; Nancy Paul
Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5166-70.
2005: Frances A Shepherd; José Rodrigues Pereira; tudor ciuleanu; Eng Huat Tan; Vera Hirsh; Sumitra Thongprasert; Daniel Campos; Savitree Maoleekoonpiroj; Michael Smylie; Renato Martins; Maximiliano van Kooten; Mircea Dediu; Brian Findlay; Dongsheng Tu; Dianne Johnston; Andrea Bezjak; Gary Clark; Pedro Santabárbara; Lesley Seymour
Erlotinib in previously treated non-small-cell lung cancer.
The New England journal of medicine 2005;353(2):123-32.
2005: K M Wasan; Paul E Goss; P H Pritchard; L Shepherd; Michael J Palmer; S Liu; Dongsheng Tu; James N Ingle; M Heath; D Deangelis; Edith A Perez
The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(5):707-15.
2005: Graeme G Duncan; Joel B Epstein; Dongsheng Tu; Samy El-Sayed; Andrea Bezjak; Jon Ottaway; Joseph L Pater
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.
Head & neck 2005;27(5):421-8.
2005: Natasha B Leighl; Luis Paz-Ares; Jean-Yves Douillard; Christian Peschel; Andrew Arnold; Alain Depierre; Armando Santoro; Daniel C Betticher; Ulrich Gatzemeier; Jacek Jassem; Jeffrey Crawford; Dongsheng Tu; Andrea Bezjak; Jeff Humphrey; Maurizio Voi; Susan Galbraith; Katherine Hann; Lesley Seymour; Frances A Shepherd
Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2831-9.
2005: Aileen M Davis; Brian O'Sullivan; Robert E Turcotte; Robert Bell; Charles Catton; Pierre Chabot; Jay Wunder; Alex Hammond; Veronique Benk; Rita Kandel; Karen Goddard; Carolyn Freeman; Anna Sadura; Benny Zee; Andrew Day; Dongsheng Tu; Joseph L Pater
Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;75(1):48-53.
2005: Ian Gilron; Joan M Bailey; Dongsheng Tu; Ronald R Holden; Donald F Weaver; Robyn L Houlden
Morphine, gabapentin, or their combination for neuropathic pain.
The New England journal of medicine 2005;352(13):1324-34.
2005: Simron Singh; Wendy Parulekar; Nevin Murray; Ronald Feld; William K Evans; Dongsheng Tu; Frances A Shepherd
Influence of sex on toxicity and treatment outcome in small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(4):850-6.
2005: David Osoba; Andrea Bezjak; Michael D Brundage; Benny Zee; Dongsheng Tu; Joseph L Pater
Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group.
European journal of cancer (Oxford, England : 1990) 2005;41(2):280-7.
2005: Ian Gilron; Elizabeth Orr; Dongsheng Tu; J Peter O'Neill; Jorge E Zamora; Allan C Bell
A placebo-controlled randomized clinical trial of perioperative administration of gabapentin, rofecoxib and their combination for spontaneous and movement-evoked pain after abdominal hysterectomy.
Pain 2005;113(1-2):191-200.
2004: Jean-Yves Douillard; Christian Peschel; Frances A Shepherd; Luis Paz-Ares; Andrew Arnold; Mary Davis; Maurizio Tonato; Michael Smylie; Dongsheng Tu; Maurizio Voi; Jeffrey Humphrey; Jon Ottaway; Katherine Young; Anne Van Vreckem; Lesley Seymour
Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;46(3):361-8.
2004: Andrea Bezjak; Dongsheng Tu; Monica Bacon; David Osoba; Benny Zee; Gavin Stuart; Josee-Anne Roy; Martine Piccart; Elizabeth Eisenhauer
Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(22):4595-603.
2004: J R Goffin; C Savage; Dongsheng Tu; L Shepherd; Timothy J Whelan; I A Olivotto
The difference between study recommendations, stated policy, and actual practice in a clinical trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(8):1267-73.
2004: Lorna Butler; Monica Bacon; Mark Carey; Benny Zee; Dongsheng Tu; Andrea Bezjak
Determining the relationship between toxicity and quality of life in an ovarian cancer chemotherapy clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2461-8.
2004: Leonard Reyno; Lesley Seymour; Dongsheng Tu; Susan Dent; Karen Gelmon; Barbara Walley; Anna Pluzanska; Vera Gorbunova; Avgust Garin; Jacek Jassem; Tadeusz Pienkowski; Janet Dancey; Laura Pearce; Mary MacNeil; Susan Marlin; David Lebwohl; Maurizio Voi; Kathleen Pritchard
Phase III study of N,N-diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine (BMS-217380-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(2):269-76.
2003: Paul E Goss; James N Ingle; Silvana Martino; Nicholas J Robert; Hyman Muss; Martine J Piccart; Monica Castiglione; Dongsheng Tu; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; Patrick Therasse; Michael J Palmer; Joseph L Pater
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.
The New England journal of medicine 2003;349(19):1793-802.
2003: Malcolm J Moore; J Hamm; Janet E Dancey; P D Eisenberg; M Dagenais; A Fields; K Hagan; B Greenberg; B Colwell; Benny Zee; Dongsheng Tu; Jon Ottaway; R Humphrey; Lesley Seymour
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3296-302.
2003: Michael Crump; Dongsheng Tu; Lois Shepherd; Mark Levine; Vivien Bramwell; Kathleen Pritchard
Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3066-71.
2003: Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
The New England journal of medicine 2003;349(3):247-57.
2003: Michael D Brundage; A Leis; Andrea Bezjak; Deb Feldman-Stewart; L Degner; K Velji; L Zetes-Zanatta; Dongsheng Tu; Paul Ritvo; Joseph L Pater
Cancer patients' preferences for communicating clinical trial quality of life information: a qualitative study.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2003;12(4):395-404.
2002: Aileen M Davis; Brian O'Sullivan; Robert S Bell; Robert E Turcotte; Charles Catton; Jay S Wunder; Pierre Chabot; A Hammond; Veronique Benk; M Isler; Carolyn Freeman; Karen Goddard; Andrea Bezjak; Rita A Kandel; Anna Sadura; A Day; K James; Dongsheng Tu; Joseph L Pater; Benny Zee
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(22):4472-7.
2002: Andrea Bezjak; Peter Dixon; Michael D Brundage; Dongsheng Tu; Michael J Palmer; Paul Blood; Clive Grafton; Catherine Lochrin; Carson Leong; Liam Mulroy; Colum Smith; James Wright; Joseph L Pater
Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15).
International journal of radiation oncology, biology, physics 2002;54(3):719-28.
2002: Samy El-Sayed; Abdenour Nabid; W Shelley; J Hay; J Balogh; M Gelinas; R MacKenzie; N Read; E Berthelet; H Lau; Joel B Epstein; P Delvecchio; P K Ganguly; F Wong; P Burns; Dongsheng Tu; Joseph L Pater
Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(19):3956-63.
2002: Joseph L Pater; Wendy Parulekar; Christopher O'Callagham; Lois Shepherd; Elizabeth Eisenhouer; Lesley Seymour; Dongsheng Tu; Keyue Ding
Ethics and industry-sponsored research.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;166(5):581-2.
2002: Robert G Pearcey; Michael D Brundage; P Drouin; J Jeffrey; D Johnston; Himu Lukka; GD MacLean; Luis Souhami; G Stuart; Dongsheng Tu
Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):966-72.
1998: Paul J Hoskins; Dongsheng Tu; K James; Joseph L Pater; B Koski
Factors predictive of survival after first relapse or progression in advanced epithelial ovarian carcinoma: a prediction tree analysis-derived model with test and validation groups.
Gynecologic oncology 1998;70(2):224-30.
1998: Mark N Levine; Vivien H C Bramwell; Kathleen I Pritchard; BD Norris; Lois E Shepherd; Hakam Abu-Zahra; Brian Findlay; David Warr; D Bowman; J Myles; Andrew Arnold; Theodore A Vandenberg; R MacKenzie; J Robert; Jon Ottaway; M Burnell; C K Williams; Dongsheng Tu
Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2651-8.